2-110768447-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142807.4(ACOXL):c.58C>T(p.Arg20Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,612,310 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001142807.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACOXL | NM_001142807.4 | c.58C>T | p.Arg20Cys | missense_variant | 2/18 | ENST00000439055.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACOXL | ENST00000439055.6 | c.58C>T | p.Arg20Cys | missense_variant | 2/18 | 2 | NM_001142807.4 |
Frequencies
GnomAD3 genomes AF: 0.0000861 AC: 13AN: 151066Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000801 AC: 20AN: 249532Hom.: 0 AF XY: 0.0000886 AC XY: 12AN XY: 135376
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461244Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 726918
GnomAD4 genome AF: 0.0000861 AC: 13AN: 151066Hom.: 1 Cov.: 31 AF XY: 0.000163 AC XY: 12AN XY: 73720
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.58C>T (p.R20C) alteration is located in exon 2 (coding exon 1) of the ACOXL gene. This alteration results from a C to T substitution at nucleotide position 58, causing the arginine (R) at amino acid position 20 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at